文献速递中医内科中医康复中药与中成药合理使用

参麦在冠状动脉旁路移植术后心脏康复中的应用:单中心随机临床试验

The utility of traditional Chinese medicine (Shenmai) in the cardiac rehabilitation after coronary artery bypass grafting: A single-center randomized clinical trial.
PubMed 文献 · Complement Ther Med · 2019-10-10

本研究为单中心随机单盲临床试验,纳入166例冠状动脉旁路移植术后患者,评估参麦联合心脏康复的疗效与安全性。结论认为参麦可改善术后早期运动耐量。

要点

  • 参麦联合心脏康复可改善CABG术后患者出院时的运动耐量。
  • 参麦组与对照组在术前及30天随访时6分钟步行距离无显著差异。
  • 研究中两组各出现一例不良事件(对照组死亡一例,参麦组卒中一例)。

核心结论

  • 参麦可改善冠状动脉旁路移植术后患者心脏康复早期的运动耐量。

研究设计与样本

  • 单中心随机单盲临床试验,样本量n=166,男性占84%,平均年龄61.12±9.13岁。

主要发现

  • 对照组出现1例死亡,参麦组出现1例卒中,均发生在术后立即。

关键数值与推荐

  • 参麦组干预:术后至出院期间每日静脉滴注参麦注射液100 ml/天(持续9.28±3.75天),随后口服参麦胶囊3.6 g/天,连续30天,并联合心脏康复。
  • 对照组仅进行心脏康复。
  • 主要测量指标为6分钟步行试验,于术前1天、出院当天和30天随访时评估。

临床怎么用

  • 对于CABG术后患者,可考虑在心脏康复基础上联合参麦治疗以改善早期运动耐量。
  • 参麦的获益主要体现在出院时,对30天时的运动耐量未见显著优势。

局限性

  • 单中心设计可能限制结果外推。
  • 样本以男性为主(84%),女性代表性不足。
  • 单盲设计可能引入偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: examine the efficacy and safety of Shenmai to the cardiac rehabilitation in patients received coronary artery bypass grafting. DESIGN: a single-center randomized, single blind clinical trial. SETTING: Department of Cardiovascular Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, China. SUBJECTS: Patients with coronary artery disease who received coronary artery bypass grafting in our center were studied. They must be competent to complete the 6-minute walking test without any assistance and without any severe comorbidity. INTERVENTIONS: in Shemmai group, the participants were treated with Shenmai injection (100 ml/day) right after the surgery to discharge for 9.28 ± 3.75 days and then capsule (3.6 g/day) sequentially for 30 days in addition to the cardiac rehabilitation. In control group, only cardiac rehabilitation was conducted. MAIN MEASURES: the 6-Minute Walking Test was measured at three time points: one day before operation, on the day of discharge and 30 days follow up. RESULTS: The sample (n = 166) was predominately male (84%), with mean age was 61.12 ± 9.13 years. There was no significant difference between groups in baseline characteristics and the procedural characteristics. There was one death in control group and one stroke in Shenmai group right after the surgery. Overall, there was group (p = .005) and time effect (p < .001) on the 6-minute walking distance. Participants in the Shenmai group walked longer distance in meters compared with control group on the day of discharge (314.54 ± 64.14 vs. 271.29 ± 76.82, P < .001), while no significant differences before operation (399.72 ± 93.19 vs. 403.67 ± 91.99, p = .78) and on 30-day follow up (436.54 ± 67.64 vs. 421.64 ± 83.53, p = .21). CONCLUSION: Shenmai improves the exercise tolerance in the early stage of the cardiac rehabilitation for patients received coronary artery bypass grafting.

来源:Complement Ther Med,查看原文。版权归原作者所有。

引用

  1. Zhang C, Zheng Y, Chen T, et al. The utility of traditional Chinese medicine (Shenmai) in the cardiac rehabilitation after coronary artery bypass grafting: A single-center randomized clinical trial. Complement Ther Med. 2019. PMID: 31779994. doi:10.1016/j.ctim.2019.102203

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。